CORE--CLINICAL
CORE--CLINICAL
批准号:
6453039
负责人:
MARK A JACOBSON
金额:
$13.19万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-10 至 2003-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The CFAR/CSG Clinical Core will provide a mechanism for multidisciplinary
collaboration among basic, clinical and behavioral scientistic to address
innovative research questions important to a better understanding of HIV
disease pathogenesis or better methods of diagnosis or treatment of HIV
disease. Specifically, this Core will facilitate translation between
basic and clinical HIV research by providing 1) expert clinical research
consultation to assist basic scientists in developing the most
appropriate protocol design for testing their specific hypotheses, 2)
experienced clinical research staff personnel to recruit subjects and
implement protocols thus providing basic scientists in developing the
most appropriate specimens needed for specific hypothesis testing, 3)
behavioral expertise to basic scientists and clinical researchers to
assist them in conceptualizing and implementing research protocols and
interpreting findings, and 4) behavioral scientists the opportunity to
test hypotheses relevant to behavioral research questions in clinical
populations. The expert clinical consultation service includes an
associate professor of medicine infectious diseases/clinical trials
specialist a research pharmacist/coordinator, an associate professor of
biostatistics, who will serve as coordinator of the Behavioral Research
Unit within in the Clinical Core, each with 8 or more years of academic,
HIV-related clinical research experience at UCSF. The Core Director and
Research Coordinator already coordinate a dynamic HIV clinical research
program as San Francisco General Hospital that is integrated into an
outpatient clinic with a patients base of greater than 3,000 individuals
at various stages of HIV disease. The Core Director, Study Coordinator
and scientists in the Behavioral Research Unit already collaborate on a
number of multidisciplinary studies to test specific hypotheses that
emerge from basic research. The full Clinical Core service will provide
consultation with the investigators to determine optimal study design,
preparation of a written study protocol and subjects informed consent
form, obtaining IRB approval and ;maintaining required IRBG
correspondence for the protocol, recruitment of subjects, obtaining and
providing investigator with all protocol-specific specimens are relevant
clinical data, long-term storage of specimens in an ultra-low temperature
specimen repository, and behavioral assessments. These services will
enable different investigators, and multidisciplinary teams of
investigators, to efficiently explore innovative hypotheses, ranging
from clinical studies of the molecular biology of HIV to behavioral
studies of cofactors in treatment response among women and minorities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV Epitope Specific T Cell Responses and Control of HIV Replication
-
批准号:7282098
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
Aberrant T Cell Function and Immunopathogenesis of CMV Immune Recovery Uveitis
-
批准号:7336264
-
项目类别:
-
资助金额:$23.11万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
HIV Epitope Specific T Cell Responses and Control of HIV Replication
-
批准号:7417845
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
Aberrant T Cell Function and Immunopathogenesis of CMV Immune Recovery Uveitis
-
批准号:7489883
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
CMV Immune Response & Long-Term Outcome of CMV Retinitis
-
批准号:6745723
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
CMV Immune Response & Long-Term Outcome of CMV Retinitis
-
批准号:6848025
-
项目类别:
-
资助金额:$25.92万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
THE ROLE OF PROTEIN LOOP FLEXIBILITY IN SUBSTRATE BINDING
-
批准号:7181783
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
AACTG 5079: PHYSIOLOGIC TESTOSTERONE
-
批准号:7203030
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
ADJUVANT RHIL-12 WITH A CYTOMEGALOVIRUS
-
批准号:7203039
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
AACTG 5079: Physiologic testosterone
-
批准号:7044942
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
A5159: HIV protease inhibitors and calcium channel blockers
-
批准号:7044955
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
ADJUVANT RHIL-12 WITH A CYTOMEGALOVIRUS
-
批准号:7044951
-
项目类别:
-
资助金额:$4.95万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
ACTG 5077: HAART/HIV compartments
-
批准号:7044920
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
AACTG A5082: Metformin/ Rosiglitazone
-
批准号:7044930
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
Adjunct rhIL-12 enhance THI response to viral vaccine?
-
批准号:6467926
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2002
-
负责人:MARK A JACOBSON
-
依托单位:
Adjunct rhIL-12 enhance THI response to viral vaccine?
-
批准号:6623575
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2002
-
负责人:MARK A JACOBSON
-
依托单位:
Adjunct rhIL-12 enhance THI response to viral vaccine?
-
批准号:6737543
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2002
-
负责人:MARK A JACOBSON
-
依托单位:
CORE--CLINICAL
-
批准号:6507450
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:MARK A JACOBSON
-
依托单位:
CORE--CLINICAL
-
批准号:6302657
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2000
-
负责人:MARK A JACOBSON
-
依托单位:
CORE--ADVANCED TECHNOLOGY LABORATORIES
-
批准号:6099319
-
项目类别:
-
资助金额:$15.75万
-
财政年份:1999
-
负责人:MARK A JACOBSON
-
依托单位:
海外基金